Viewing Study NCT04286750


Ignite Creation Date: 2025-12-24 @ 5:05 PM
Ignite Modification Date: 2026-02-25 @ 11:47 PM
Study NCT ID: NCT04286750
Status: COMPLETED
Last Update Posted: 2021-01-20
First Post: 2020-02-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study in Healthy Subjects to Examine the Safety and Tolerability of ACT-1004-1239 Given as Multiple, Gradually Increasing Doses and to Examine the Effects of ACT-1004-1239 on the Body and the Way the Body Takes up, Distributes, and Gets Rid of ACT-1004-1239
Sponsor: Idorsia Pharmaceuticals Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module